在活检路径中注射止血基质：疗效、潜在并发症及此类并发症的处理
Injecting hemostatic matrix in the path of biopsies: efficacy, potential complications, and the management of such complications.
作者信息
Rahal Junior Antonio, Falsarella Priscila Mina, Ferreira Vinicius Tadeu Rodrigues, Mariotti Guilherme Cayres, de Queiroz Marcos Roberto Gomes, Garcia Rodrigo Gobbo
机构信息
MD, Physician in the Department of Interventional Radiology of the Hospital Israelita Albert Einstein, São Paulo, SP, Brazil.
Researcher in the Department of Interventional Radiology of the Hospital Israelita Albert Einstein, São Paulo, SP, Brazil.
出版信息
Radiol Bras. 2018 Mar-Apr;51(2):102-105. doi: 10.1590/0100-3984.2017.0011.
OBJECTIVE
To describe the technique of injecting hemostatic matrix, as well as the experience of our interventional radiology department in its application.
MATERIALS AND METHODS
We conducted a single-center study with retrospective analysis of the experience of our group in the use of hemostatic gelatin matrix in percutaneous biopsies.
RESULTS
In a total of 73 biopsies in different organs, such as the liver, kidney, and spleen, hemostatic gelatin matrix was introduced into the coaxial needle. The only complication observed was migration of the hemostatic matrix to the left kidney collecting system, and that was resolved with clinical treatment. There were no cases of bleeding after the injection of hemostatic matrix.
CONCLUSION
The use of hemostatic matrices in the path of percutaneous biopsies is another tool available for consideration in minimally invasive procedures.
目的
描述注射止血基质的技术以及我们介入放射科在其应用方面的经验。
材料与方法
我们进行了一项单中心研究，回顾性分析了我们团队在经皮活检中使用止血明胶基质的经验。
结果
在总共73例不同器官（如肝脏、肾脏和脾脏）的活检中，将止血明胶基质引入同轴针。观察到的唯一并发症是止血基质迁移至左肾集合系统，经临床治疗后得到解决。注射止血基质后无出血病例。
结论
在经皮活检路径中使用止血基质是微创操作中可供考虑的另一项工具。
Zotero 插件